Table of Contents
Journal of Allergy
Volume 2012, Article ID 253879, 6 pages
http://dx.doi.org/10.1155/2012/253879
Research Article

Quality of Life Improvement with Sublingual Immunotherapy: A Prospective Study of Efficacy

1Allergy Associates of La Crosse and Mayo Clinic Health System Franciscan Healthcare-La Crosse-Onalaska, WI 54650, USA
2Allergychoices Inc., Onalaska, WI 54650, USA
3College of Science and Health, University of Wisconsin-La Crosse, La Crosse, WI 54601, USA
4Allergy and Asthma Center, Hagerstown, MD 21740, USA

Received 29 September 2011; Revised 23 November 2011; Accepted 24 November 2011

Academic Editor: Nazan Cobanoglu

Copyright © 2012 Mary S. Morris et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. D. Brown, C. Hankin, D. Scott et al., “Characteristics associated with premature discontinuation of allergen immunotherapy among children and adults: findings from a large, single-specialty allergy practice,” Journal of Allergy and Clinical Immunology, vol. 123, no. 3, p. 728, 2009. View at Google Scholar
  2. “Committee on the safety of medicines update: desensitizing vaccines,” British Medical Journal, vol. 293, p. 948, 1986.
  3. V. di Rienzo, F. Marcucci, P. Puccinelli et al., “Long-lasting effect of sublingual immunotherapy in children with asthma due to house dust mite: a 10-year prospective study,” Clinical and Experimental Allergy, vol. 33, no. 2, pp. 206–210, 2003. View at Publisher · View at Google Scholar · View at Scopus
  4. P. Berto, F. Frati, and C. Incorvaia, “Economic studies of immunotherapy: a review,” Current Opinion in Allergy and Clinical Immunology, vol. 8, no. 6, pp. 585–589, 2008. View at Publisher · View at Google Scholar · View at Scopus
  5. D. Larenas-Linnemann, “Sublingual immunotherapy in children: complete and updated review supporting evidence of effect,” Current Opinion in Allergy and Clinical Immunology, vol. 9, no. 2, pp. 168–176, 2009. View at Publisher · View at Google Scholar · View at Scopus
  6. M. H. Tucker and M. S. Tankersley, “Perception and practice of sublingual immunotherapy among practicing allergists,” Annals of Allergy, Asthma and Immunology, vol. 101, no. 4, pp. 419–425, 2008. View at Google Scholar
  7. G. Scadding and S. Durham, “Mechanisms of sublingual immunotherapy,” Journal of Asthma, vol. 46, no. 4, pp. 322–334, 2009. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  8. A. Gungor, St. Houser, B. Aquino et al., “A comparison of skin endpoint titration and skin-prick testing in the diagnosis of allergic rhinitis,” Ear, Nose and Throat Journal, vol. 83, no. 1, pp. 54–60, 2004. View at Google Scholar · View at Scopus
  9. La Crosse Method Sublingual Immunotherapy Practice Protocol, Allergychoices, La Crosse, Wis, USA, 2008.
  10. H. Nelson, “Allergen immunotherapy: where is it now?” Journal of Allergy and Clinical Immunology, vol. 119, no. 4, pp. 769–777, 2007. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  11. E. Álvarez-Cuesta, P. Berges-Gimeno, E. Gonzalez-Mancebo, E. Fernández-Caldas, J. Cuesta-Herranz, and M. Casanovas, “Sublingual immunotherapy with a standardized cat dander extract: evaluation of efficacy in a double blind placebo controlled study,” Allergy, vol. 62, no. 7, pp. 810–817, 2007. View at Publisher · View at Google Scholar · View at PubMed
  12. H. S. Nelson, “Advances in upper airway diseases and allergen immunotherapy,” Journal of Allergy and Clinical Immunology, vol. 119, no. 4, pp. 872–880, 2007. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  13. V. Bordignon and S. E. Burastero, “Multiple daily administrations of low-dose sublingual immunotherapy in allergic rhinoconjunctivitis,” Annals of Allergy, Asthma and Immunology, vol. 97, no. 2, pp. 158–163, 2006. View at Google Scholar · View at Scopus
  14. E. Juniper and G. H. Guyatt, “Development and testing of a new measure of health status for clinical trials in rhinoconjunctivitis,” Clinical and Experimental Allergy, vol. 21, no. 1, pp. 77–83, 1991. View at Google Scholar · View at Scopus
  15. R. Dahl, A. Kapp, G. Colombo et al., “Efficacy and safety of sublingual immunotherapy with grass allergen tablets for seasonal allergic rhinoconjunctivitis,” Journal of Allergy and Clinical Immunology, vol. 118, no. 2, pp. 434–440, 2006. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  16. S. Durham, W. Yang, M. Pedersen, N. Johansen, and S. Rak, “Sublingual immunotherapy with once-daily grass allergen tablets: a randomized controlled trial in seasonal allergic rhinoconjunctivitis,” Journal of Allergy and Clinical Immunology, vol. 117, no. 4, pp. 802–809, 2006. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  17. D. Wilson, M. Lima, and S. Durham, “Sublingual immunotherapy for allergic rhinitis: systematic review and meta-analysis,” Allergy, vol. 60, no. 1, pp. 4–12, 2005. View at Google Scholar · View at Scopus
  18. M. Penagos, E. Compalati, F. Tarantini et al., “Efficacy of sublingual immunotherapy in the treatment of allergic rhinitis in pediatric patients 3 to 18 years of age: a meta-analysis of randomized, placebo-controlled, double-blind trials,” Annals of Allergy, Asthma and Immunology, vol. 97, no. 2, pp. 141–148, 2006. View at Google Scholar · View at Scopus
  19. E. Valovirta, L. Jacobsen, C. Ljørring, A. Koivikko, and J. Savolainen, “Clinical efficacy and safety of sublingual immunotherapy with tree pollen extract in children,” Allergy, vol. 61, no. 10, pp. 1177–1183, 2006. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  20. C. Rolinck-Werninghaus, H. Wolf, C. Liebke et al., “A prospective, randomized, double-blind, placebo-controlled multi-centre study on the efficacy and safety of sublingual immunotherapy (SLIT) in children with seasonal allergic rhinoconjunctivitis to grass pollen,” Allergy, vol. 59, no. 12, pp. 1285–1293, 2004. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  21. H. S. Nelson, “Multiallergen immunotherapy for allergic rhinitis and asthma,” Journal of Allergy and Clinical Immunology, vol. 123, pp. 1103–1110, 2009. View at Google Scholar
  22. S. K. Wise, J. Woody, S. Koepp, and R. J. Schlosser, “Quality of life outcomes with sublingual immunotherapy,” American Journal of Otolaryngology, vol. 30, no. 5, pp. 305–311, 2009. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  23. D. L. Morris, “Treatment of respiratory disease with ultra-small doses of antigens,” Annals of Allergy, vol. 28, no. 10, pp. 494–500, 1970. View at Google Scholar · View at Scopus
  24. M. S. Morris, M. J. Schnitzius, and R. D. Duquette, “Impact of sublingual immunotherapy on allergic conditions associated with asthma in pediatric patients,” in Proceedings of the American College of Allergy, Asthma & Immunology, Anaheim, Calif, USA, 2005.
  25. D. L. Morris, “Intradermal testing and sublingual desensitization for nickel,” Cutis, vol. 61, no. 3, pp. 12–132, 1998. View at Google Scholar
  26. M. S. Morris and M. Learned, “Sublingual immunotherapy for treatment of poison ivy dermatitis,” in Proceedings of the American College of Allergy, Asthma & Immunology, Philadelphia, Pa, USA, 2006.